Research from PrEPVacc

Research dissemination from the PrEPVacc study

Featured
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
Research
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
Research
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
Research
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
Research
Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Research
Research
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
Research
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
Research
Research
Attitudes towards PrEP uptake and adherence explored in Masaka, Uganda
Research
Attitudes towards PrEP uptake and adherence explored in Masaka, Uganda
Research
Research
HIV R4P Virtual: HIV prevalence and incidence among female sex workers participating in a phase IIB HIV vaccine preparedness study in Dar es Salaam,Tanzania
Research
HIV R4P Virtual: HIV prevalence and incidence among female sex workers participating in a phase IIB HIV vaccine preparedness study in Dar es Salaam,Tanzania
Research
Research
HIV R4P Virtual: Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda
Research
HIV R4P Virtual: Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda
Research
Research
HIV R4P Virtual: Changes in risky sexual behaviour among adult men and women in an HIV vaccine preparedness study in south-western Uganda
Research
HIV R4P Virtual: Changes in risky sexual behaviour among adult men and women in an HIV vaccine preparedness study in south-western Uganda
Research
Research